Ustekinumab for painful Crohn’s bowel narrowing
Treatments studied
Part of Digestive system clinical trials.
This trial tests ustekinumab, a medicine that calms immune inflammation, to see if it can improve symptoms in people with Crohn’s disease that causes bowel narrowing. It may help if your Crohn’s symptoms come from strictures (narrowed areas) seen on scans or endoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a doctor’s diagnosis of moderate to severe Crohn’s disease
- In the past 8 weeks, you’ve had obstructive (blockage-like) symptoms
- Imaging or endoscopy must show one or more Crohn’s strictures (narrowings)
- Your strictures were not recently treated with a stricture procedure or surgery in the last 6 months
- You have no urgent need for surgery or endoscopy within the next 2 months (as your clinician judges)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines, Guselkumab and Ustekinumab, for people with Crohn's disease that causes narrowing (strictures) in the bowel. It aims to find which works better to improve symptoms and avoid the need for more procedures.
This trial tests a new medicine called risankizumab for people with Crohn's disease that has caused a narrowing (stricture) in the intestine. It compares risankizumab to another drug, ustekinumab, to see which works better for this type of Crohn's.
This study tailors ustekinumab (Stelara) treatment specifically for people with fistulizing Crohn's disease around the anus. It aims to find the best way to use this medicine to improve symptoms like pain and drainage from fistulas.
This study looks at inflammation just before a narrowed section of the bowel in people with Crohn’s disease, using planned endoscopic balloon dilation. It may help doctors better understand what drives narrowing and inflammation so treatment can be timed and chosen more effectively.
This Phase 1 study uses a special camera to track how ustekinumab (a common biologic medicine) spreads in inflamed tissue. It aims to help researchers understand where the drug goes in Crohn’s disease and psoriasis, especially when standard treatments haven’t worked.
This trial compares two ways to treat narrowed areas (strictures) in the gut caused by Crohn's disease: endoscopic strictureplasty versus balloon dilation. It aims to see which method works better for people whose strictures are manageable with a scope.
Hear when a new Stricture; Bowel trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.